ETF

JEPI Is an Income Machine—But These 3 Dividend Stocks Don’t Cap Your Upside

JEPI's monthly paycheck looks irresistible until you see exactly what the fund surrenders to produce it. Three Dividend Kings quietly sidestep that tradeoff, and the difference compounds in ways most income investors never stop to calculate.

Published September 8, 2026, 7:50am ET · 4 min read

The ETF Examiner desk. Editor: Ryne Mauck.

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

A stylized digital financial chart on a deep blue background, showcasing a bright blue line graph with glowing points, an orange line graph, and numerous green and blue bar chart elements. A prominent glowing upward arrow is visible in the upper right, indicating growth.
This digital representation of a financial chart, featuring upward trends and vibrant data visualization, illustrates the strong market performance and high income potential discussed in the article. © SylisiaDesign / Shutterstock.com

The JPMorgan Equity Premium Income ETF (NYSEARCA:JEPI) has become the default retirement income holding for millions of investors, and it is easy to see why. JEPI pays monthly, sits on roughly $44.7 billion in net assets, and threw off $4.58 per share in trailing twelve-month distributions against a $57.43 share price. That headline rate is the pitch. The tension is what the fund gives up to produce it, and whether three boring Dividend Kings, Coca-Cola (NYSE:KO | KO Price Prediction), Johnson & Johnson (NYSE:JNJ), and Procter & Gamble (NYSE:PG), would have served the same reader better.

What JEPI Actually Sells You

JEPI owns a diversified basket of large-cap equities and pairs it with equity-linked notes tied to selling call options on the S&P 500. Selling a call means the fund collects a premium up front in exchange for capping how much it can earn if stocks rally. That premium becomes the monthly distribution. In flat or choppy markets it works beautifully. In rising markets the fund cashes the premium and watches the underlying stocks run away without it.

Over the past year JEPI returned 9.97% in price. Over five years the price change was 41.86%. Distributions add to that, but the ceiling is real: a covered call fund cannot compound the way its underlying holdings can, because it keeps selling that upside. Distribution amounts also swing month to month, from $0.34 to $0.54 in 2025 alone, so the “stable income” framing is looser than it looks.

Option premium income and ELN payouts are generally taxed as ordinary income at federal rates up to 37%. Qualified dividends from KO, JNJ, and PG are taxed at 0%, 15%, or 20%. For a retiree in a taxable brokerage account, that spread quietly eats a meaningful slice of every JEPI check.

Coca-Cola: The Compounding Machine

Coca-Cola yields roughly 2.30%, hardly a JEPI substitute on headline. What it does have is a $0.53 quarterly dividend, a track record of 60-plus consecutive annual increases, and a business throwing off guided $12.4 billion in free cash flow this year. CFO John Murphy noted net debt leverage of 1.4 times EBITDA, “below our target range of 2 to 2.5 times.” KO returned 32.4% over the past year and 178% over ten. The upside JEPI sells, KO keeps. Risk: at a P/E near 29, buyers are not paying a bargain price for that quality.

Johnson & Johnson: Yield With a Pipeline Behind It

Johnson & Johnson raised its dividend to $1.34 per quarter, its 64th consecutive annual increase. Q1 revenue reached $24.06 billion, with management guiding full-year revenue to $100.3 to $101.3 billion. CFO Joe Wolk stated the priority plainly: “We also remain committed to returning capital directly to shareholders, primarily through our dividend.” He added that JNJ has “28 platforms, each generating more than $1 billion in annual revenue” underpinning a path to double-digit growth by decade’s end. The stock delivered 59.94% over the past year. Risk: the Stelara biosimilar erosion of 59.7% and the pending Orthopaedics separation add moving parts.

Procter & Gamble: The Slowest Reliable Winner

Procter & Gamble just marked 70 consecutive years of dividend increases and 136 straight years of payments. FY2026 free cash flow was $15.84 billion, and the company plans roughly $10 billion in dividends and $5 billion in buybacks for FY2027. The quarterly rate stepped up to $1.0885. Total return has lagged: PG returned -4.42% over the past year and 15.96% over five. Risk: FY2027 guidance flags a roughly $1 billion commodity headwind, an 8% drag on core EPS. Owned for its consistency, not its dazzle.

When JEPI Is Still the Right Answer

An investor in a Roth or IRA who needs maximum monthly income, has no interest in growth, and values a smoother ride than single stocks can offer is exactly who JEPI was built for. The ordinary-income tax drag disappears inside a tax-advantaged account, and diversification across dozens of names removes single-stock blowup risk.

Bottom Line for Income Investors

For investors holding JEPI in a taxable account with a horizon longer than five years, an equal-weight KO, JNJ, and PG basket is worth evaluating: a lower starting yield and single-name concentration in exchange for qualified-dividend taxation, uncapped equity upside, and dividend growth measured in decades. For tax-sheltered accounts where the priority is the biggest monthly check, JEPI’s structure continues to do what it was designed to do.

Contact [email protected] for any questions or corrections.

Chris Lange

Chris Lange is a writer for 24/7 Wall St., based in Houston. He has covered financial markets over the past decade with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields. Currently, Lange's focus is on military and geopolitical topics. Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications. A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and startups.

All articles →